50

Makers Laboratories LtdBOM 506919 Stock Report

Last reporting period 30 Sep, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.005

Micro

Exchange

XBOM - Bombay Stock Exchange

506919.BO Stock Analysis

50

Uncovered

Makers Laboratories Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.005

Dividend yield

2.50 %

Shares outstanding

5.9 B

Makers Laboratories Ltd. is a pharmaceutical company, which engages in manufacturing and marketing of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 121 full-time employees. The firm is engaged in the manufacturing and marketing of pharmaceuticals. The firm operates through the pharmaceuticals segment. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (anti-cough range) and Exylin (Amoxycillin range). Its Inspira retail packs division includes acid regulatory (PPIS), anthelmintics, anti-allergic, anti-asthmatic, anti-biotics, anti-diabetics, anti-diarrheal, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensives, and others. Its Experia bulk packs division includes amoxycillin 250 mg capsules, betamethasone 0.5 mg tablets, cetirizine HCL 10 mg tablets, chloramphenicol capsules 250 mg, chloroquine phosphate 250 mg tablets, chlorpheniramine maleate 4 mg tablets, ciprofloxacin hydrochloride 250 mg tablets, and others.

View Section: Eyestock Rating